Skip to the reading
MOTS-cField notes

Field guide / Start here

MOTS-c therapy.
Start with the questions.

A plain-language guide to understanding MOTS-c and finding care. Curious is fine. A treatment claim still needs proof.

What is MOTS-c?

MOTS-c is a peptide: a small piece of protein that the body makes itself.

The body’s instructions for making MOTS-c are stored in mitochondria. These are tiny parts inside cells that help make energy.

Start my question list
MOTS-c evidence map: cell and mouse work, measurements in people, and no published human treatment results.

By September 30, 2026, no published study had reported what happened when people were given MOTS-c.

A study in China had begun, but its results were still missing.

Source behind the evidence map Source: the study in China

Is it an approved US treatment?

The Food and Drug Administration (FDA) is the US agency for reviewing medicines.

MOTS-c has no US FDA approval in records checked September 30, 2026.

Source: FDA’s MOTS-c review

Ask for the missing step

What would count as an answer?

Is a study in people underway?

A trial is a test of a treatment in people.

The MOTS-c study is registered: its plan is listed on ClinicalTrials.gov, a public website for study records.

The record checked September 30, 2026 says the study began in February 2026. It was still looking for volunteers in China.

A listed start date does not tell us how many people received MOTS-c. The treatment results are still needed.

Your starting notes

What are you hoping to change?

Put the goal in your own words. Then turn it into a question for a clinician, a health professional who can assess your concern.

My starting point

Save notes in this browser. On a shared device, clear them when finished.

Notes are not saved yet.

Continue the field notesQuestions for care